APA

Assem M., Elsabaawy M., Abdelrashed M., Elemam S., Khodeer S., Hamed W., Abdelaziz A. & El-Azab G. (20170118). Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study. : Hepatology international.

Chicago

Assem M, Elsabaawy M, Abdelrashed M, Elemam S, Khodeer S, Hamed W, Abdelaziz A and El-Azab G. 20170118. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study. : Hepatology international.

Harvard

Assem M., Elsabaawy M., Abdelrashed M., Elemam S., Khodeer S., Hamed W., Abdelaziz A. and El-Azab G. (20170118). Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study. : Hepatology international.

MLA

Assem M, Elsabaawy M, Abdelrashed M, Elemam S, Khodeer S, Hamed W, Abdelaziz A and El-Azab G. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study. : Hepatology international. 20170118.